The crypto market has seen significant activity around the
MLN Coin (also known as
Enzyme), a digital asset designed for decentralized asset management. Italy's Intesa tested Bitcoin with a 1 million euro investment, while
Donald Trump profited massively from crypto coin sales. Interestingly, despite these developments, Binance delisted MDT/BTC and MLN/BTC coins, maintaining its focus on improving quality and user experience.
Coinbase, a major platform for trading crypto, included Enzyme Token (MLN), Gitcoin (GTC), and Amp (AMP) in its listings. This move followed
Coinbase's data breach, which led to a potential loss of up to $400 million. Amid the pump and dump tactics observed in the crypto market, Enzyme Crypto's price showed a marked increase of +52%. Meanwhile, Japan's DMM Bitcoin reported a loss of over $300 million of cryptocurrency, and the Dutch central bank levied a fine of 3.3 million euros on Coinbase. Despite the controversies, Coinbase managed to pay $50 million to settle the NY state investigation, planning to invest an additional $50 million in their compliance efforts. Amid various threats and opportunities, the market response to MLN Coin will continue to be shaped by multiple factors.
MLN Coin News Analytics from Tue, 02 Jul 2013 07:00:00 GMT to Sun, 20 Jul 2025 06:22:30 GMT -
Rating 4
- Innovation 5
- Information 6
- Rumor 3
